Joel Greenblatt fit · Magic Formula - high ROIC + cheap EV/EBIT
Is BioCryst Pharmaceuticals, Inc. (BCRX) a Joel Greenblatt Stock?
Partial match - either cheap or high-quality, but not both.
61/100
CMixed signals
5/5 criteria passed
Joel Greenblatt's Criteria, Applied to BCRX
EBIT/EV yield ≥ 10%
key14.8%
ROIC ≥ 25%
key93.9%
EV/EBIT ≤ 12
6.8x
Gross margin ≥ 30%
97.7%
Earnings yield ≥ 6%
13.7%
How BCRX Scores on Other Strategies
Live Financial Snapshot
Market cap
$2.26B
P/E (TTM)
-
ROIC (TTM)
-121.96%
Gross margin
18.89%
Other Joel Greenblatt fit reports
Frequently Asked Questions
What is BCRX's Joel Greenblatt fit score?
BCRX scores 61/100 on our Joel Greenblatt fit engine - grade C. Partial match - either cheap or high-quality, but not both.
Does Joel Greenblatt actually own BCRX?
Our score is computed from financial fundamentals against Joel Greenblatt's published criteria. We don't claim that Joel Greenblatt personally owns or recommends BCRX.
How often is this score updated?
BCRX's Joel Greenblatt fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Key terms in this analysis
Educational tool, not investment advice. Scores are computed from publicly-available financial data against published investing-strategy criteria. We do not claim that Joel Greenblatt personally owns or recommends BCRX.